Lifeward (LFWD) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.02% |
| Dec 31, 2025 | 67.85% |
| Sep 30, 2025 | 81.23% |
| Jun 30, 2025 | 66.04% |
| Mar 31, 2025 | 72.33% |
| Dec 31, 2024 | 75.98% |
| Sep 30, 2024 | 67.31% |
| Jun 30, 2024 | 74.00% |
| Mar 31, 2024 | 66.55% |
| Dec 31, 2023 | 58.64% |
| Sep 30, 2023 | 55.96% |
| Jun 30, 2023 | 26.14% |
| Mar 31, 2023 | 25.08% |
| Dec 31, 2022 | 23.14% |
| Sep 30, 2022 | 18.88% |
| Jun 30, 2022 | -22.67% |
| Mar 31, 2022 | -22.53% |
| Dec 31, 2021 | -334.09% |
| Sep 30, 2021 | -405.41% |
| Jun 30, 2021 | -356.74% |
| Mar 31, 2021 | -306.04% |
| Dec 31, 2020 | -25.21% |
| Sep 30, 2020 | 11.56% |
| Jun 30, 2020 | 41.53% |
| Mar 31, 2020 | -87.34% |
| Dec 31, 2019 | -70.26% |
| Sep 30, 2019 | -290.25% |
| Jun 30, 2019 | -164.50% |
| Mar 31, 2019 | -0.50% |
| Dec 31, 2018 | 34.47% |
| Sep 30, 2018 | 59.55% |
| Jun 30, 2018 | 44.05% |
| Mar 31, 2018 | 48.52% |
| Dec 31, 2017 | 38.48% |
| Sep 30, 2017 | -4.27% |
| Jun 30, 2017 | -3.63% |
| Mar 31, 2017 | 21.46% |
| Dec 31, 2016 | -32.51% |
| Sep 30, 2016 | 50.68% |
| Jun 30, 2016 | 49.68% |
| Mar 31, 2016 | 41.00% |
| Dec 31, 2015 | 58.92% |
| Sep 30, 2015 | 47.28% |
| Jun 30, 2015 | -3,348.23% |
| Dec 31, 2014 | -390.93% |
| Sep 30, 2014 | -1,120.79% |